Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
University of Florida
University of Florida
University of Pittsburgh
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Peter MacCallum Cancer Centre, Australia
Amager Hospital
University Hospital Olomouc
Peking University First Hospital
University of California, San Francisco
University of Cadiz
Huazhong University of Science and Technology
University of Utah
The First Affiliated Hospital of Xiamen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Asan Medical Center
West China Hospital
Peking University First Hospital
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Dokuz Eylul University
Dokuz Eylul University
Dana-Farber Cancer Institute
Sun Yat-sen University
Zhejiang University
University of Eastern Finland
Essen Biotech
University of Vienna
University of Chicago
Clinique Paris-Bercy
Osijek University Hospital
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Cedars-Sinai Medical Center
Tseung Kwan O Hospital, Hong Kong
Chung Shan Medical University
Université Catholique de Louvain
Royal Marsden NHS Foundation Trust
UNC Lineberger Comprehensive Cancer Center
Ezisurg Medical Co. Ltd.
University Hospital, Brest
The University of Hong Kong
Tri-Service General Hospital
Nantes University Hospital
Peking University First Hospital
Leiden University Medical Center
SMED Clinical Research
Istanbul University
University of Rochester
Shanghai Chest Hospital
Johns Hopkins University
Memorial Sloan Kettering Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
Gadjah Mada University